Always supportive and understanding.
Tim Morgan serves as a Research Technician in the Department of Paediatrics and Child Health at the University of Otago's Dunedin School of Medicine, within the Faculty of Medicine. He earned his MSc in Biochemistry from the University of Otago in 2000, completing it in Professor Julian Eaton-Rye's laboratory. Since then, Morgan has been an integral part of the Clinical Genetics Research Laboratory in Professor Stephen Robertson's Clinical Genetics Group, also known as the Laboratory for Genomic Medicine. His research focuses on the genetic interactions and biochemistry of genes and proteins implicated in congenital malformations in children, contributing to advancements in paediatric genetics and the elucidation of rare heritable disorders.
Morgan has co-authored over 30 peer-reviewed publications in prestigious journals such as Brain, Nature Genetics, American Journal of Human Genetics, and European Journal of Human Genetics. Key contributions include 'A functional role for septin-2 in the maintenance of the axon initial segment and in human cognitive development' (Brain, 2025), 'The hinge-1 domain of Flna is not necessary for diverse physiological functions in mice' (European Journal of Clinical Investigation, 2024), 'Pathogenic FLNA variants affecting the hinge region of filamin A are associated with male survival' (American Journal of Medical Genetics Part A, 2024), 'FLNA-filaminopathy skeletal phenotypes are not due to an osteoblast autonomous loss-of-function' (Bone Reports, 2023), 'Deletion of the last two exons of FGF10 in a family with LADD syndrome and pulmonary acinar hypoplasia' (European Journal of Human Genetics, 2022), 'Impaired retinoic acid receptor-γ signalling underlies a heritable form of urothelial carcinoma' (HGG Advances, 2026), 'Mutations in genes encoding the cadherin receptor-ligand pair CDH4 and CDH6 cause skeletal dysplasia' (Nature Genetics, 2013), 'Germline mutations in WTX cause a sclerosing skeletal dysplasia' (Nature Genetics, 2009), 'Mutations in DVL1 cause an osteosclerotic form of Robinow syndrome' (American Journal of Human Genetics, 2015), 'Autosomal dominant frontometaphyseal dysplasia: Delineation of the clinical phenotype' (2017), and 'Exon skip-inducing variants in FLNA in an attenuated form of frontometaphyseal dysplasia' (2021). These works have significantly impacted the field by identifying disease-causing mutations and characterizing phenotypes in skeletal dysplasias, filaminopathies, and other developmental conditions.
